Phosphatidyl choline

Phosphatidylcholine/Drug Interactions:

  • Antilipemic agentsAntilipemic agents: In human research, phosphatidylcholine reduced clofibrate-induced increases in LDL cholesterol, although changes were not statistically significant (14).
  • Gastrointestinal agents, miscellaneousGastrointestinal agents, miscellaneous: In human research, phosphatidylcholine reduced the clinical activity index in patients with ulcerative colitis (11).
  • Hepatoprotective agentsHepatoprotective agents: In human research, phosphatidylcholine reduced biopsy scores in hepatitis patients treated with maintenance immunosuppressive therapy (4). In patients with hepatitis C, the biochemical response rate was higher in hepatitis patients treated with subcutaneous interferon (12).
  • ImmunosuppressantsImmunosuppressants: In human research, phosphatidylcholine reduced biopsy scores in hepatitis patients treated with maintenance immunosuppressive therapy (4). In patients with hepatitis C, the biochemical response rate was higher in hepatitis patients treated with subcutaneous interferon (12).

    • Phosphatidylcholine/Herb/Supplement Interactions:

  • AntilipemicsAntilipemics: In human research, phosphatidylcholine reduced clofibrate-induced increases in LDL cholesterol, although changes were not statistically significant (14).
  • Gastrointestinal herbs and supplementsGastrointestinal herbs and supplements: In human research, phosphatidylcholine reduced the clinical activity index in patients with ulcerative colitis (11).
  • Hepatoprotective herbs and supplementsHepatoprotective herbs and supplements: In human research, phosphatidylcholine reduced biopsy scores in hepatitis patients treated with maintenance immunosuppressive therapy (4). In patients with hepatitis C, the biochemical response rate was higher in hepatitis patients treated with subcutaneous interferon (12).
  • ImmunosuppressantsImmunosuppressants: In human research, phosphatidylcholine reduced biopsy scores in hepatitis patients treated with maintenance immunosuppressive therapy (4). In patients with hepatitis C, the biochemical response rate was higher in hepatitis patients treated with subcutaneous interferon (12).

    • Phosphatidylcholine/Food Interactions:

  • Insufficient available evidence.

    • Phosphatidylcholine/Lab Interactions:

  • Liver enzymesLiver enzymes: In human research, phosphatidylcholine reduced liver enzymes, including alanine transaminase (ALT) (12).
  • Plasma lipidsPlasma lipids: In human research, phosphatidylcholine reduced clofibrate-induced increases in LDL cholesterol, although changes were not statistically significant (14).